Search

Displaying results 6021 - 6030 of 6189 in total
  1. Drug

    TAS-106

    go.drugbank.com/drugs/DB06656
    Investigational

    TAS-106 is a new nucleoside antimetabolite. TAS-106 has demonstrated strong antitumor activity without serious toxicity in nude rat models bearing human tumours .

  2. Drug

    Arverapamil

    go.drugbank.com/drugs/DB06669
    Investigational

  3. Drug

    Sotirimod

    go.drugbank.com/drugs/DB05680
    Experimental

  4. Drug

    FX06

    go.drugbank.com/drugs/DB05685
    Investigational

    FX06 is a naturally occurring peptide derived from the neo-N-terminus of fibrin (Bbeta(15-42)). It prevents leukocyte migration through the gap junctions of endothelial cells. FX06 has proven safe in acute and subchronic toxicological st...

  5. Drug

    Casopitant

    go.drugbank.com/drugs/DB06634
    Investigational

    Categories: Neurokinin-1 Receptor Antagonists
  6. Drug

    Prasterone sulfate

    go.drugbank.com/drugs/DB05804
    Investigational

    DHEA sulfate is the major steroid of the fetal adrenal. DHEA-S is the principal adrenal androgen and is secreted together with cortisol under the control of ACTH and prolactin. DHEA-S is elevated with hyperprolactinemia.

  7. Drug

    Naronapride

    go.drugbank.com/drugs/DB05542
    Investigational

    Categories: Serotonin Receptor Agonists, Serotonin 5-HT4 Receptor Agonists
  8. Drug

    NV-07a

    go.drugbank.com/drugs/DB05845
    Experimental

    NV-07a is topical skin repair compound protecting skin from sun-induced immunosuppression and UV-induced damage.

  9. Drug

    ENMD-1198

    go.drugbank.com/drugs/DB05959
    Experimental

  10. Drug

    Linsitinib

    go.drugbank.com/drugs/DB06075
    Investigational

    An orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity.